Team:Fatih Turkey/confirmation

From 2011.igem.org

(Difference between revisions)
Line 555: Line 555:
  <div class="bar-title">
  <div class="bar-title">
      <h2 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Experiments</h2>
      <h2 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Experiments</h2>
-
      <h5 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Confirmation</h5>
+
      <h5 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Charactarization</h5>
    </div>
    </div>
  <div class="bar-title-sh-left"></div>
  <div class="bar-title-sh-left"></div>
Line 568: Line 568:
         <div style="float: left; width: 220px; border-radius: 10px; position: absolute; top: 50px; left: 0; background: #EEE; border: solid 3px #666;">
         <div style="float: left; width: 220px; border-radius: 10px; position: absolute; top: 50px; left: 0; background: #EEE; border: solid 3px #666;">
             <ol>
             <ol>
-
               <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/confirmation">Confirmation</a></li>
+
               <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/confirmation">Charactarization</a></li>
                
                
               </li>
               </li>
Line 575: Line 575:
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments1">Exposure Experiment</a></li>
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments1">Exposure Experiment</a></li>
                    
                    
-
                  <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments2">The Suicide Experiment of E.Coli</a></li>
+
               
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiment3C">Inhibition in Liquid Culture Assay</a></li>
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiment3C">Inhibition in Liquid Culture Assay</a></li>
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments4">Inhibition in Supernatant Assay</a></li>
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments4">Inhibition in Supernatant Assay</a></li>
 +
<li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments2">The Suicide Experiment of E.Coli</a></li>
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments5">Fenton Reagent Assay</a></li>
                   <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments5">Fenton Reagent Assay</a></li>
<li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments6">Existence of Reflectin</a></li>
<li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments6">Existence of Reflectin</a></li>
Line 584: Line 585:
         </div>
         </div>
         <div style="width: 654px; border: solid 3px #666; border-radius: 10px; padding-left: 80px; margin-left: 170px;">
         <div style="width: 654px; border: solid 3px #666; border-radius: 10px; padding-left: 80px; margin-left: 170px;">
-
          <table width="606" height="203" border="0">
+
         
 +
<table width="606" height="203" border="0">
   <tr>
   <tr>
     <td width="600" valign="top"><p><strong>CHARACTERIZATION</strong><br />
     <td width="600" valign="top"><p><strong>CHARACTERIZATION</strong><br />
Line 590: Line 592:
       <table border="1" cellspacing="0" cellpadding="0">
       <table border="1" cellspacing="0" cellpadding="0">
         <tr>
         <tr>
-
           <td width="307" valign="top"><br />
+
           <td width="307" height="35" valign="top"><strong>Subparts</strong> </td>
-
              <strong>Subparts</strong> </td>
+
           <td width="307" valign="top"><p><strong>Parts</strong></p></td>
           <td width="307" valign="top"><p><strong>Parts</strong></p></td>
         </tr>
         </tr>
Line 632: Line 633:
   </tr>
   </tr>
</table>
</table>
 +
         </div>
         </div>
     </div>
     </div>

Revision as of 15:47, 28 October 2011

deneme baslik

CHARACTERIZATION
Before starting assays; we needed to be sure that our genes had been cloned correctly. In order to use our parts in our experiments, we confirmed our parts via electrophoresis as it can be seen in image A. Following parts are fully confirmed:

Subparts

Parts

BBa_K541501

BBa_K541515

BBa_K541502

BBa_K541545

BBa_K541503

BBa_K541596

BBa_K541504

BBa_K541915

BBa_K541505

BBa_K541800

BBa_K541506

BBa_K541516

 

BBa_K541526

 

BBa_K541546

After electrophoresis results; we furthermore performed sequencing and imaging tests to characterize our BioBricks. For BBa_541505 and BBa_541506; we added a GFP sequence and transformated into E.coli. This has characterized our main proteins. cDNA sequencing for these parts was also done successfully.
In addition, BBa_541800 is transformated into B.subtilis and successfully imaged red that shows RFP region and therefore plasmid backbone works properly.
We characterized BBa_K541545, BBa_K541515 and BBa_K541915 via sequencing.